Attached files

file filename
EX-99 - EXHIBIT 99.1 - Revolutions Medical CORPrmcp20130620_8kex99-1.htm

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): June 17, 2013

 

REVOLUTIONS MEDICAL CORPORATION.

(Exact name of registrant as specified in its charter)



Nevada

 

000-28629

 

73-1526138

(State or other jurisdiction

of incorporation)

 

(Commission File Number)

 

(IRS Employer

Identification No.)

 

 


670 Marina Drive, 3rd Floor

Charleston, SC 29492

 
 

(Address of Principal Executive Offices)

 


(843) 971-4848

Registrant’s telephone number, including area code
  

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

 Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

 Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

 Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

 Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 
 

 

 

Item 5.02 Departure of Directors or Certain Officers; Election of Directors, Appointment of Certain Officers;
Compensatory Arrangements of Certain Officers.

 

On June 15, 2013, Burt Hodges resigned as Chief Financial Officer of Revolutions Medical Corporation.

 

 

Item 9.01 Financial Statements and Exhibits.

 

(d) Exhibits

 

Exhibit No.

 

Description

 

 

 

99.1*

 

Letter of Resignation from Burt Hodges, dated June 15, 2013

 

*filed herewith

 

 
 

 

 

SIGNATURE

 

            Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

REVOLUTIONS MEDICAL CORPORATION

Date: June 20, 2013

By:

/s/ Rondald L. Wheet                                         

 

 

Rondald L. Wheet

 

 

Chief Executive Officer

 

 

 

 

 

.